Research ArticleOriginal Research
Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis
Neta Goldschmidt, Leora Zamir, Alina Poperno, Nathan R. Kahan and Ora Paltiel
The Journal of the American Board of Family
Medicine November 2016, 29 (6) 702-709; DOI: https://doi.org/10.3122/jabfm.2016.06.150393
Neta Goldschmidt
From the Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (NG, LZ, OP); the Enforcement and Inspection Division, Israeli Ministry of Health, Jerusalem, Israel (AP); the Medical Division, Leumit Health Services, Tel-Aviv, Israel (NRK); the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (NRK); and the School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (OP).
MDLeora Zamir
From the Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (NG, LZ, OP); the Enforcement and Inspection Division, Israeli Ministry of Health, Jerusalem, Israel (AP); the Medical Division, Leumit Health Services, Tel-Aviv, Israel (NRK); the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (NRK); and the School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (OP).
MDAlina Poperno
From the Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (NG, LZ, OP); the Enforcement and Inspection Division, Israeli Ministry of Health, Jerusalem, Israel (AP); the Medical Division, Leumit Health Services, Tel-Aviv, Israel (NRK); the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (NRK); and the School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (OP).
MPH, B.Pharm, B.ScNathan R. Kahan
From the Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (NG, LZ, OP); the Enforcement and Inspection Division, Israeli Ministry of Health, Jerusalem, Israel (AP); the Medical Division, Leumit Health Services, Tel-Aviv, Israel (NRK); the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (NRK); and the School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (OP).
RPh, MHA, PhDOra Paltiel
From the Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (NG, LZ, OP); the Enforcement and Inspection Division, Israeli Ministry of Health, Jerusalem, Israel (AP); the Medical Division, Leumit Health Services, Tel-Aviv, Israel (NRK); the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (NRK); and the School of Public Health, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (OP).
MDCM, MSc, FRCPC
References
- 1.↵
- Sergentanis TN,
- Zagouri F,
- Tsilimidos G,
- et al
- 2.↵
- 3.↵
- Kyle RA,
- Durie BGM,
- Rajkumar SV,
- et al
- 4.↵
- 5.↵
- Durie BG,
- Salmon SE
- 6.↵
- Greipp PR,
- San Miguel J,
- Durie BG,
- et al
- 7.↵
- Bianchi G,
- Kyle RA,
- Colby CL,
- et al
- 8.↵
- Mateos M-V,
- Hernández M-T,
- Giraldo P,
- et al
- 9.↵
- Deyo RA,
- Rainville J,
- Kent DL
- 10.↵
- Kyle RA,
- Rajkumar SV
- 11.↵
- Dobson CM,
- Russell AJ,
- Rubin GP
- 12.↵National Patient Safety Agency, Royal College of General Practitioners. Delayed diagnosis of cancer: thematic review. Data report, ref. no. 0968. London: NHS England; 2010. Available from: http://www.nrls.npsa.nhs.uk/resources/?EntryId45=69894. Accessed September 28, 2016.
- 13.↵
- Hill A,
- Elkin K,
- Davidson N
- 14.↵
- Green LA,
- Fryer GE,
- Yawn BP,
- Lanier D,
- Dovey SM
- 15.↵
- Jarvik JG,
- Deyo RA
- 16.↵
- Kariyawasan CC,
- Hughes DA,
- Jayatillake MM,
- Mehta AB
- 17.↵
- Friese CR,
- Abel GA,
- Magazu LS,
- Neville BA,
- Richardson LC,
- Earle CC
- 18.↵
- van den Hoogen HM,
- Koes BW,
- van Eijk JT,
- Bouter LM
- 19.↵
- Dispenzieri A,
- Kyle R,
- Merlini G,
- et al
- 20.↵
- Dimopoulos M,
- Kyle R,
- Fermand J-P,
- et al
- 21.↵
- Espersen F,
- Birgens HS,
- Hertz JB,
- Drivsholm A
- 22.↵
- Kyle RA,
- Gertz MA,
- Witzig TE,
- et al
- 23.↵
- 24.↵
- Rajkumar SV,
- Kyle RA
- 25.↵
In this issue
The Journal of the American Board of Family
Medicine
Vol. 29, Issue 6
November-December 2016
Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis
Neta Goldschmidt, Leora Zamir, Alina Poperno, Nathan R. Kahan, Ora Paltiel
The Journal of the American Board of Family
Medicine Nov 2016, 29 (6) 702-709; DOI: 10.3122/jabfm.2016.06.150393
Jump to section
Related Articles
- No related articles found.
Cited By...
- Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care
- Improving the diagnostic pathway in patients presenting with acute kidney injury secondary to de novo multiple myeloma: a short report
- Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
- Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis
- Re: Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis
- Bread and Butter of Family Medicine: Guidelines, Population Screening, Diagnostic Evaluations, and Practice Models